AwardTape · Defense awards · Research and development · Health R&D · HT942525P0014
HT942525P0014: $50K purchase order to Mitochon Pharmaceuticals, Inc
Mitochon Pharmaceuticals, Inc holds a purchase order from Defense Health Agency with $50K obligated since Oct 2023, against a ceiling of $150K. Latest action Nov 7, 2024.
Mp201 drug development/synthesis
| PIID | HT942525P0014 |
|---|---|
| Type | purchase order |
| Company | Mitochon Pharmaceuticals, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN14 HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $50K |
| Total obligated (lifetime) | $50K |
| Ceiling (base and all options) | $150K |
| Base date | Nov 7, 2024 |
| Latest action | Nov 7, 2024 |
| End date | Oct 24, 2027 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial